Atractylenolide II Suppresses Glycolysis and Induces Apopto-sis by Blocking the PADI3-ERK Signaling Pathway in Endo-metrial Cancer Cells

ABSTRACT: Atractylenolide II (AT-II), the major bioactive compound of Atractylodes macrocephala exhibits anticancer activity against many types of tumors, but the roles and the potential mechanisms in endometrial cancer remain unclear. To explore a novel therapeutic target of AT-II for the clinical therapy of endometrial cancer, the high-throughput sequence was performed.

ORGANISM(S): Homo sapiens

PROVIDER: GSE252780 | GEO | 2024/03/20

REPOSITORIES: GEO